BioSpace News Archive

The Artificial Red Blood Cells Market is forecast to reach USD 19.11 Billion by 2027, according to a new report by Reports and Data.

Arbor Biotechnologies today announced that it has entered into an agreement with Acuitas Therapeutics, a leader in the development of lipid nanoparticles (LNP).

Aclaris Therapeutics, Inc. today announced a non-exclusive patent license agreement with Eli Lilly and Company (Lilly).

Bio-Techne Corporation announced the publication of a study in the Green Analytical Chemistry journal, titled Establishment of a Platform Imaged Capillary Isoelectric Focusing Characterization Method for Adeno-Associated Virus Capsid Proteins.

Liminal BioSciences Inc. announced today that, effective immediately, its long-term legacy Master Services Agreement, entered into in May 2015 as amended, relating to its previously owned plasma-derived therapeutics business (“CDMO Agreement”), was terminated by mutual agreement between the parties.

Can-Fite BioPharma Ltd today announced financial results for the quarter ended June 30, 2022.

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced financial results for the second quarter ended June 30, 2022 and provided an update on the Company’s business developments.

Alterity Therapeutics today announced the Company’s Phase 2 clinical trial of ATH434 for the treatment of patients with Multiple System Atrophy (MSA) is now open for enrolment in the United Kingdom.

Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of cancers, announced that the first colorectal cancer patient in the RAD-18-002 phase 2A clinical trial has been treated with its drug candidate, Radspherin®.

Evotec SE announced that the Company expands its clinical and commercial manufacturing platform for small molecule therapeutics by acquiring Central Glass Germany GmbH from the Japanese chemical manufacturing company Central Glass Co. Ltd.